SFDA · US FDA · EMA · Health Canada · CMS · NHSBSA · WHO
Registered medicines
Products listed by each authority per active substance or brand, with published prices and authorised indications.
- SFDA13,487products in the SFDA drug list9 Apr 2026
- US FDA50,462US FDA approved products (Drugs@FDA)9 Oct 2026
- EMA2,351EU medicines authorised through EMA10 Oct 2026
- Health Canada11,463products marketed in Canada8 Oct 2026
- CMS30,048US price lines (NADAC)7 Oct 2026
- NHSBSA3,534NHS Drug Tariff prices (England and Wales)1 Oct 2026
- WHO813WHO essential-medicine entries5 Sep 2025
Loading the list…
Counts are products (registers) or price lines (NADAC, NHS Drug Tariff). Select a row for the entries.
| Active substance | SFDA | US FDA | EMA | Canada | US price | NHS price | WHO EML |
|---|
Sources and reuse
SFDA Saudi Food and Drug Authority (SFDA)
- Human drug list — 13,487 records, data of 9 Apr 2026.
Source: Saudi Food and Drug Authority, human drug list 4-2026, as published by the Council of Health Insurance. Indications: CHI Daman Drug Formulary (DDF), ed59 (20 Aug 2026).
US FDA U.S. Food and Drug Administration
- Drugs@FDA data files — 50,462 records, data of 9 Oct 2026.
Source: U.S. FDA, Drugs@FDA. Licence: Public domain (U.S. Government work). Terms of reuse.
EMA European Medicines Agency
- Medicines data — centrally authorised human medicines — 2,351 records, data of 10 Oct 2026.
Source: European Medicines Agency. Licence: Reuse authorised with acknowledgement of the source (EMA legal notice). Terms of reuse.
Health Canada Health Canada
- Drug Product Database — marketed products — 11,463 records, data of 8 Oct 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, Drug Product Database). Terms of reuse.
CMS Centers for Medicare & Medicaid Services (CMS)
- National Average Drug Acquisition Cost (NADAC) — 30,048 records, data of 7 Oct 2026.
Source: CMS, NADAC. Licence: Public domain (U.S. Government work). Terms of reuse.
NHSBSA NHS Business Services Authority (NHSBSA)
- Drug Tariff Part VIIIA — 3,534 records, data of 1 Oct 2026.
Drug Tariff Part VIIIA, NHSBSA Copyright 2026. Licence: Open Government Licence v3.0. Terms of reuse.
WHO World Health Organization
- Model List of Essential Medicines — 813 records, data of 5 Sep 2025.
WHO Model List of Essential Medicines – 24th List (2025). Geneva: World Health Organization; 2025. Licence: CC BY 3.0 IGO. WHO electronic Essential Medicines List (eEML), World Health Organization, 2020. https://list.essentialmeds.org/ (beta version 1.0). Licence: CC BY 3.0 IGO. This is an adaptation of the original work: the list is regrouped by active substance here. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy. The original edition is the binding and authentic edition. Terms of reuse.
Each tab lists only what that authority publishes: the SFDA human drug list (public prices; indications from the CHI Daman Drug Formulary), US FDA approvals (Drugs@FDA), EMA's centrally authorised medicines, Health Canada's marketed products, US pharmacy acquisition costs (NADAC), NHS England and Wales reimbursement prices (Drug Tariff Part VIIIA) and the WHO Model List. Products are grouped by active substance; salts and esters of one substance are shown together, and US names are listed under the international name (paracetamol for acetaminophen). Price lines are placed by the substance named in their description.
Not a substitute for the official registers, the product information or a pricing decision.